Anvisa nyatujuan pendaptaran versi anyar Mounjaro, ubar dumasar-tirzepatide dituduhkeun pikeun pengobatan sawawa kalayan diabetes tipe 2. kaputusan, diterbitkeun dina Diário Oficial of...
Anvisa approved the registration of a new version of Mounjaro, a tirzepatide-based medication indicated for the treatment of adults with type 2...